Rare Oncology News
Disease Profile
Glutathione synthetase deficiency
Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
<1 / 1 000 000
Age of onset
Neonatal
ICD-10
D55.1
Inheritance
Autosomal dominant A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease.
Autosomal recessive Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype.
X-linked
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
Mitochondrial or multigenic Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Not applicable
Other names (AKA)
5-Oxoprolinuria; Oxoprolinase deficiency; Pyroglutamic aciduria;
Categories
Metabolic disorders
Summary
Glutathione synthetase deficiency is a genetic
Glutathione synthetase deficiency is caused by genetic changes (pathogenic variants or
Symptoms
Symptoms of moderate glutathione synthetase deficiency may include hemolytic anemia as well as a buildup of a substance called 5-oxoproline in the urine (5-oxoprolinuria). The build up of certain substances in the body can also cause metabolic acidosis, which happens when there is too much acid in the body. Signs of metabolic acidosis may include nausea, vomiting, and fatigue.[3]
The severe form of glutathione synthetase deficiency usually causes the same signs and symptoms seen in the milder forms of the deficiency, but can also affect the brain, which causes neurological problems. Neurological problems may include
In many cases, signs of moderate or severe deficiency are apparent during infancy. Symptoms of mild deficiency may not be recognized until later in life.[1]
This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.
Medical Terms | Other Names |
Learn More:
HPO ID
|
---|---|---|
80%-99% of people have these symptoms | ||
Abnormality of |
0010978 | |
Abnormality of the nervous system |
Neurologic abnormalities
Neurological abnormality
[ more ] |
0000707 |
Chronic metabolic acidosis | 0001996 | |
Hemolytic anemia | 0001878 | |
Reduced glutathione synthetase level | 0003343 | |
Percent of people who have these symptoms is not available through HPO | ||
Ataxia | 0001251 | |
0000007 | ||
Difficulty articulating speech
|
0001260 | |
Increased level of L-pyroglutamic acid in urine | 0410132 | |
Intellectual disability |
Mental deficiency
Mental retardation
Mental retardation, nonspecific
Mental-retardation
[ more ] |
0001249 |
Intention tremor | 0002080 | |
Neutropenia |
Low blood neutrophil count
Low neutrophil count
[ more ] |
0001875 |
Pigmentary retinopathy | 0000580 | |
Psychotic mentation | 0001345 | |
Seizure | 0001250 | |
Spastic tetraparesis | 0001285 |
Cause
People with pathogenic variants in the GSS gene do not have enough working glutathione synthetase, and therefore their cells do not have enough glutathione to neutralize harmful substances or to break down 5-oxoproline. This causes 5-oxoproline to build up in the body. When 5-oxoproline builds up in the body, it causes the symptoms of glutathione synthetase deficiency.[1][4]
Because there are mild, moderate, and severe forms of glutathione synthetase deficiency, it is thought that there may be other environmental and genetic factors that may impact the severity of symptoms associated with the deficiency.[2]
Diagnosis
Treatment
People with glutathione synthetase deficiency require close follow-up by doctors who are familiar with the deficiency. Therefore, a consultation with genetics specialists such as a biochemical geneticist,
Related diseases
Related diseases are conditions that have similar signs and symptoms. A health care provider may consider these conditions in the table below when making a diagnosis. Please note that the table may not include all the possible conditions related to this disease.
Conditions with similar signs and symptoms from Orphanet
|
---|
Other causes of 5-oxoprolinuria include 5-oxoprolinase deficiency (see this term), diet (certain infant formulas and tomato juice), severe burns, Stevens-Johnson syndrome (see this term), inborn errors of metabolism not involving the gamma-glutamyl cycle, e.g. X-linked ornithine trancarbamylase deficiency, urea cycle defects, tyrosinemia, as well as homocystinuria (see these terms), drug metabolism (paracetamol, vigabatrin, flucloxacillin, netimicin), prematurity, malnutrition, pregnancy and nephropatic cystinosis.
Visit the Orphanet disease page for more information.
|
Organizations
Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
Organizations Supporting this Disease
-
Genetic Metabolic Dietitians International
P.O. Box 1462
Hillsborough, NC 27278
E-mail: info@gdmi.org
Website: https://www.gmdi.org/ -
Metabolic Support UK
5 Hilliards Court
Sandpiper Way
Chester Business Park
Chester, CH4 9QP United Kingdom
Toll-free: 0800 652 3181
Telephone: 0845 241 2173
E-mail: https://www.metabolicsupportuk.org/contact-us
Website: https://www.metabolicsupportuk.org -
Organic Acidemia Association
9040 Duluth Street
Golden Valley, MN 55427
Telephone: 763-559-1797
Fax: 866-539-4060
E-mail: mkstagni@gmail.com
Website: https://www.oaanews.org/
Learn more
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
Where to Start
- The Organic Acidemia Association provides further information on this topic. Click on Organic Acidemia Association to view this information page.
- The Merck Manual provides information on metabolic acidosis. Click on Merck Manual to view this information page.
- Genetics Home Reference (GHR) contains information on Glutathione synthetase deficiency. This website is maintained by the National Library of Medicine.
- The National Organization for Rare Disorders (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.
In-Depth Information
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- MeSH® (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Glutathione synthetase deficiency. Click on the link to view a sample search on this topic.
Selected Full-Text Journal Articles
- The Orphanet Journal of Rare Diseases has published an article with information on this condition. This journal is affiliated with the Orphanet reference portal for information on rare diseases and orphan drugs.
References
- Glutathione synthetase deficiency. Genetics Home Reference. May 2015; https://ghr.nlm.nih.gov/condition/glutathione-synthetase-deficiency.
- Larsson A. Glutathione Synthetase Deficiency. National Organization for Rare Disorders. 2015; https://rarediseases.org/rare-diseases/glutathione-synthetase-deficiency/.
- Lewis, III JL. Metabolic Acidosis. Merck Manual. March 2018; https://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/acid-base-regulation-and-disorders/metabolic-acidosis.
- GSS gene. Genetics Home Reference. March 2015; https://ghr.nlm.nih.gov/gene/GSS.
- Saadeh-Haddad R. Glutathione Synthetase Deficiency. Medscape. May 18, 2017; https://emedicine.medscape.com/article/944368-overview.
- Larsson A and Ristoff E. Glutathione synthetase deficiency. Orphanet. March 2007; https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=32.
- Atwal PS, Medina CR, Burrage LC, and Sutton VR. Nineteen-year follow-up of a patient with severe glutathione synthetase deficiency. Journal of Human Genetics. July 2016; 61(7):668-672. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26984560/.
Rare Oncology News